Fletcher Spaght, Inc. logo

Fletcher Spaght, Inc.

North America, Massachusetts, United States, Boston

Description

Fletcher Spaght, Inc. provides strategy and financial assistance to new ventures including start-ups.

Investor Profile

Fletcher Spaght, Inc. has backed more than 31 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 10% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series C (35%)
  • Series B (23%)
  • Series D (16%)
  • Series Unknown (13%)
  • Series A (6%)
  • Debt Financing (3%)
  • Series E (3%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
  • Software
  • Therapeutics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fletcher Spaght, Inc. frequently co-invest with?

Syngenta Ventures
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 7
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
The Aurora Funds
North America, North Carolina, United States, Durham
Co-Investments: 5
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 4
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 3
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 3
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
Early Stage Partners
North America, Ohio, United States, Cleveland
Co-Investments: 4

What are some of recent deals done by Fletcher Spaght, Inc.?

PhaseBio Pharmaceuticals

Malvern, Pennsylvania, United States

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

BiotechnologyMedicalMedical DevicePharmaceutical
Series DSep 5, 2018
Amount Raised: $34,000,000
Cheetah Medical

Newton Center, Massachusetts, United States

Cheetah Medical is a device company developing non-invasive cardiac output and hemodynamic monitoring devices.

BiotechnologyDeveloper PlatformMedical
Series CSep 12, 2017
Amount Raised: $11,760,000
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Series BMar 13, 2017
Amount Raised: $8,260,313
Swift Biosciences

Ann Arbor, Michigan, United States

Swift Biosciences develops molecular biology reagents for research and diagnostic applications.

BiotechnologyHealth CareHealth Diagnostics
Series CApr 15, 2016
Amount Raised: $3,000,000
PhaseBio Pharmaceuticals

Malvern, Pennsylvania, United States

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

BiotechnologyMedicalMedical DevicePharmaceutical
Series CMar 12, 2015
Amount Raised: $40,000,000
CardioFocus

Marlborough, Massachusetts, United States

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

BiotechnologyHealth CareMedical DevicePharmaceutical
Debt FinancingMay 9, 2014
Amount Raised: $2,378,923
Cheetah Medical

Newton Center, Massachusetts, United States

Cheetah Medical is a device company developing non-invasive cardiac output and hemodynamic monitoring devices.

BiotechnologyDeveloper PlatformMedical
Series CFeb 24, 2014
Amount Raised: $28,849,535
Metabolon

Morrisville, North Carolina, United States

Metabolon offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceSoftware
Series EJan 6, 2014
Amount Raised: $14,999,980
Swift Biosciences

Ann Arbor, Michigan, United States

Swift Biosciences develops molecular biology reagents for research and diagnostic applications.

BiotechnologyHealth CareHealth Diagnostics
Series BOct 17, 2013
Amount Raised: $7,000,000
SurgiQuest

Orange, Connecticut, United States

SurgiQuest is a surgical device company in the field of minimally-invasive access technology.

BiotechnologyHealth CareMedicalMedical Device
Series DDec 5, 2012
Amount Raised: $7,500,000

Find More Investors Like Fletcher Spaght, Inc.

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Fletcher Spaght, Inc. | Pipeseed